Barinthus Biotherapeutics
Developing T cell immunotherapeutics
- B2B
About Barinthus Biotherapeutics
A clinical-stage biopharmaceutical company developing T cell immunotherapeutic candidates for chronic infectious diseases, autoimmunity, and cancer treatment
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Harwell, Oxfordshire, United Kingdom
- Founded
- 2016
- Revenue
- $15MFY2025, publicly reported
- Website
- barinthusbio.com
Barinthus Biotherapeutics at a glance
Barinthus Biotherapeutics is a B2B company in the Biotechnology Research industry, headquartered in Harwell, Oxfordshire, United Kingdom.
Barinthus Biotherapeutics was founded in 2016.
Barinthus Biotherapeutics has 11–50 employees.
Barinthus Biotherapeutics's revenue is $15M (FY2025, publicly reported).
Frequently asked questions about Barinthus Biotherapeutics
What is Barinthus Biotherapeutics's revenue?
Barinthus Biotherapeutics's revenue is $15M (FY2025, publicly reported).
How many employees does Barinthus Biotherapeutics have?
Barinthus Biotherapeutics has 11–50 employees.
Where is Barinthus Biotherapeutics headquartered?
Barinthus Biotherapeutics is headquartered in Harwell, Oxfordshire, United Kingdom.
Selling to companies like Barinthus Biotherapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies